|
Volumn 93, Issue 18, 2001, Pages
|
Re: Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes.
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
ESTROGEN RECEPTOR;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
TAMOXIFEN;
TUMOR PROTEIN;
ADJUVANT CHEMOTHERAPY;
ADULT;
AGED;
BIOLOGICAL MODEL;
BONE MARROW EXAMINATION;
BREAST TUMOR;
CHEMISTRY;
COMPARATIVE STUDY;
DISEASE FREE SURVIVAL;
FEMALE;
HUMAN;
LETTER;
LYMPH NODE;
MASTECTOMY;
METASTASIS;
METHODOLOGY;
MIDDLE AGED;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
PROGNOSIS;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS, HORMONAL;
BONE MARROW EXAMINATION;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
COMBINED MODALITY THERAPY;
DISEASE-FREE SURVIVAL;
FEMALE;
HUMANS;
LYMPH NODES;
MASTECTOMY;
MIDDLE AGED;
MODELS, BIOLOGICAL;
NEOPLASM METASTASIS;
NEOPLASM PROTEINS;
PROGNOSIS;
RECEPTORS, ESTROGEN;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
TAMOXIFEN;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 0035913816
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/93.18.1420 Document Type: Letter |
Times cited : (1)
|
References (0)
|